Press release
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce a suite of comprehensive mRNA-LNP Vaccine [https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/mrna-lnp-vaccine-laboratory-process-development-assay] Laboratory Process Development Assays. This latest addition to CD Bioparticles' extensive service portfolio is specifically designed for the rapid and efficient development of mRNA-LNP vaccines.
The mRNA molecule is well known to the public through COVID-19 and the mRNA vaccine made from it is characterized by rapid blocking of pathogen mutation response, simple production process and scale-up. Detection and validation methods are the basis for quality control of mRNA LNP vaccines. Therefore, R&D companies should establish detection methods for the characteristics of mRNA, liposomes and formulations, as well as related impurities and other key quality attributes of mRNA vaccines to ensure the safety and efficacy of mRNA-LNP vaccines.
CD Bioparticles now offers a comprehensive portfolio of laboratory assays designed to support every stage of mRNA-LNP vaccine development. These assays provide researchers with the tools they need to optimize their vaccine formulations and ensure their safety and efficacy, accelerating the path to clinical trials and commercialization. In addition, CD Bioparticles' team of scientific experts is available to work with researchers to develop custom assays to meet their specific needs.
CD Bioparticles mRNA-LNP vaccine assay portfolio encompasses a variety of methodologies, including Cellular Uptake Studies,mRNA Transfection Efficiency Study, In Vivo Biodistribution, Histopathological Studies, Biochemical Indicators Testing, and Detection of Antigen-Specific T Cells. By leveraging CD Bioparticles' expertise in analysis and characterization, researchers can gain deeper insights into the properties and performance of their vaccines, enabling them to make informed decisions during the development process.
For example, in the mRNA Transfection Efficiency Study, DC2.4 cells are selected as the model cells for the infection experiment. After infecting the cells with GFP-mRNA-LNP, the intracellular GFP signal will be observed by fluorescence microscopy. CD Bioparticles can assist customers with immunostaining studies that not only examine the efficiency of mRNA transmission, but also help to identify the specific cell types that are transfected into a specific type of organ.
CD Bioparticles also offers In Vivo Biodistribution services. To visualize the distribution of LNP in an organism, the professionals use fluorescent dyes (e.g., DiD and DiO) and luciferase for labeling. Typically, luciferase mRNA (Luc-mRNA) is used as a model mRNA to follow the distribution of the expressed protein in vivo. After intravenous injection of Luc-mRNA-LNP, heart, liver, spleen, lung, kidney and lymph node tissues are isolated. The tissues will be visualized using the IVIS Spectral Live Image System. This will facilitate visualization studies of organ distribution and duration of protein activity production.
CD Bioparticles' new mRNA-LNP assays are available to researchers and vaccine developers worldwide. The company is committed to providing cutting-edge technologies and services that support the advancement of biotechnology and improve human health. For more information about the services, please visit https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/mrna-lnp-vaccine-laboratory-process-development-assay.
About CD Bioparticles
CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-announces-comprehensive-assay-portfolio-for-mrnalnp-vaccine-development]
State: New York
Country: United States
Website: https://www.cd-bioparticles.net/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development here
News-ID: 3506683 • Views: …
More Releases from ABNewswire
Repair, Rebuild, Enhance: The Unified AI Restoration Workflow in Wondershare Fil …
Image: https://www.abnewswire.com/upload/2025/12/b542da8d8f891e35c98b4af92fd7a56b.jpg
Restoring broken or dull videos once required multiple editing programs. Editors used one tool for noise reduction, another for color correction, and another to fix missing frames. Each tool worked independently, slowing down the process and breaking creative focus. This often resulted in heavy workflows, long hours, and inconsistent results across clips.
The AI Restoration Workflow in Wondershare Filmora V15 [https://filmora.wondershare.com/?utm_source=other_media_sites&utm_medium=pr&utm_campaign=aparticle&utm_content=text_21111566_2025-02-10] solves these issues by combining AI technologies-including repair, rebuild,…
Pulsetto Launches Innovative Anxiety Management Tools Designed to Improve Overal …
Image: https://www.abnewswire.com/upload/2025/12/f629e7623c9097f49a3e85da14d339c0.jpg
Anxiety has become a regular part of life for many, affecting well-being, relationships, and the ability to focus every day. The good news: there are more ways than ever to manage anxiety in 2025, tools, habits, and techniques that fit busy, modern lifestyles and truly make a difference.
Click here to discover the best anxiety tools for adults - PULSETTO [https://pulsetto.tech/collections/best-anxiety-tools-for-adults]
Understanding the Anxiety Surge in 2025
More than 1 billion people…
AI in Post-Production: How Wondershare Filmora V15 Accelerates Professional Rest …
Manual editing used to be essential for turning raw footage into a polished video, but the demands of modern workflows have far surpassed what manual corrections alone can achieve. Today, with the undeniable power of AI, Wondershare Filmora V15 [https://filmora.wondershare.com/?utm_source=other_media_sites&utm_medium=pr&utm_campaign=aparticle&utm_content=text_21111566_2025-02-10] automates much of that work. From generating media to refining it, Filmora supports creators at every stage. It compensates for low-quality recording equipment with one-click enhancement tools and removes unwanted…
Northwest Exteriors Urges Homeowners to Replace Windows Before Winter Weather Ar …
Rancho Cordova, CA - December 1, 2025 - With colder temperatures quickly approaching, Northwest Exteriors is encouraging homeowners across California and Hawaii to take proactive steps in preparing their homes by investing in energy-efficient replacement windows. Known for their expert craftsmanship and commitment to energy savings, Northwest Exteriors helps residents stay warm, reduce utility costs, and eliminate drafts before winter sets in.
Replacing outdated or damaged windows before winter not only…
More Releases for Bioparticles
CD Bioparticles Strengthens Drug Development Pipeline with Comprehensive Animal …
CD Bioparticles launches Animal Models Evaluation services to accelerate the clinical translation and registration of novel therapeutics.
New York, USA - November 24, 2025 - CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its comprehensive Animal Models Evaluation [https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/animal-models-evaluation] services to accelerate the clinical translation and registration of novel therapeutics, by providing essential in vivo data under both Non-GLP and…
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported.
Flow cytometry is a convenient detection…
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.
The polystyrene family, a group of polymers derived from…
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications.
Low dispersion index polymers are polymeric compounds with low molecular…
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
